Choose HA

Analysis of over 1,100 patients demonstrated SUPARTZ FX to be effective in treating knee OA* pain with a safety profile similar to placebo.

Full article available at Elsevier.

Intraarticular HA treatment was significantly more effective than saline vehicle in mild to moderate OA* of the knee for the 13-week post injection period of the study.

Article abstract available at PubMed.gov.

Significant improvement in pain, physical function and balance tests was demonstrated after five weekly SUPARTZ FX injections in geriatric patients with knee OA*. The effect had rapid onset at 1 week and may last for 6 months.

Full article available at Elsevier.